| P50 | author | Yehuda Shoenfeld | Q1515807 |
| P2093 | author name string | R M R Pereira | |
| | J F Carvalho | |
| P2860 | cites work | Atherosclerosis — An Inflammatory Disease | Q26776972 |
| | Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis | Q28209813 |
| | Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation | Q28275313 |
| | Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity | Q28344371 |
| | Atherosclerosis | Q28345191 |
| | Inflammation in atherosclerosis | Q29547428 |
| | Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences | Q31135771 |
| | LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis | Q31807216 |
| | Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 |
| | Atherogenesis and autoimmune disease: the model of lupus | Q36283443 |
| | Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis | Q36283486 |
| | Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases | Q36399112 |
| | Mechanisms of dyslipoproteinemias in systemic lupus erythematosus | Q36502252 |
| | Vaccines for the prevention of cardiovascular disease | Q36625905 |
| | Systemic lupus erythematosus and "lupus dyslipoproteinemia". | Q37055444 |
| | Vaccination and autoimmune rheumatic diseases | Q37242804 |
| | Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study | Q37897616 |
| | Antibody against cholesteryl ester transfer protein (CETP) elicited by a recombinant chimeric enzyme vaccine attenuated atherosclerosis in a rabbit model | Q40413205 |
| | The safety and immunogenicity of a CETP vaccine in healthy adults | Q40574796 |
| | Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus | Q41608189 |
| | Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient mice | Q42817247 |
| | Natural antibodies against phosphorylcholine as potential protective factors in SLE. | Q46560299 |
| | Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis | Q46652738 |
| | Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension | Q46820023 |
| | Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction | Q47273525 |
| | Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I. | Q47442034 |
| | Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis | Q50070810 |
| | A CD99-related antigen on endothelial cells mediates neutrophil but not lymphocyte extravasation in vivo | Q51049436 |
| | DNA vaccination against VEGF receptor 2 reduces atherosclerosis in LDL receptor-deficient mice. | Q51766388 |
| | Inhibition of cholesterol atherosclerosis by immunisation with beta-lipoprotein. | Q53741016 |
| | Circulating Antibodies Recognizing Oxidatively Modified Low-Density Lipoprotein in Children | Q58493544 |
| P433 | issue | 13 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 1209-1212 | |
| P577 | publication date | 2009-11-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Vaccination, atherosclerosis and systemic lupus erythematosus | |
| P478 | volume | 18 | |